Show simple item record

dc.contributor.authorKarki, Pratap
dc.contributor.authorKe, Yunbo
dc.contributor.authorWilliams, Charles H. (Charles Houston)
dc.contributor.authorHong, Charles C., 1967-
dc.contributor.authorBirukov, Konstantin G.
dc.contributor.authorBirukova, Anna A.
dc.date.accessioned2022-03-30T13:04:07Z
dc.date.available2022-03-30T13:04:07Z
dc.date.issued2022-04
dc.identifier.urihttp://hdl.handle.net/10713/18404
dc.descriptionPoster presented at Experimental Biology, April 2-5, 2022en_US
dc.language.isoen_USen_US
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internationalen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.meshReceptors, G-Protein-Coupleden_US
dc.subject.meshEndothelium--physiopathologyen_US
dc.subject.meshEndothelium--metabolismen_US
dc.subject.meshAnti-Inflammatory Agents--pharmacologyen_US
dc.subject.meshLung Injuryen_US
dc.titleGPR68 Inhibition with a Novel Group of Ogremorphin Inhibitors Upregulate Endothelial Barrier Function and Protect Against Bacterial Pathogens or Acidosis induced Inflammation in Lung Endotheliumen_US
dc.typePoster/Presentationen_US
refterms.dateFOA2022-03-30T13:04:08Z


Files in this item

Thumbnail
Name:
SOM_KarkiKe_2022.pdf
Size:
866.7Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 International
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International